HuGE Literature Finder
Records
1
-
22
| Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer. Research square 2023 3 . Adamson Aaron W, Ding Yuan Chun, Steele Linda, Leong Lucile A, Morgan Robert, Wakabayashi Mark T, Han Ernest S, Dellinger Thanh H, Lin Paul S, Hakim Amy A, Wilczynski Sharon, Warden Charles D, Tao Shu, Bedell Victoria, Cristea Mihaela C, Neuhausen Susan |
| Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation. Cancer 2023 1 129 (6): 845-859. Jin Juan, Cao Jianing, Li Bin, Li Ting, Zhang Jian, Cao Jun, Zhao Mingchun, Wang Leiping, Wang Biyun, Tao Zhonghua, Hu Xich |
| Spectrum of Germline Mutations Within Fanconi Anemia-Associated Genes Across Populations of Varying Ancestry. JNCI cancer spectrum 2022 8 5 (1): . Chan Sock Hoai, Ni Ying, Li Shao-Tzu, Teo Jing Xian, Ishak Nur Diana Binte, Lim Weng Khong, Ngeow Joan |
| Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2). Cancer genetics 2021 10 258-259 101-109. McReynolds Lisa J, Biswas Kajal, Giri Neelam, Sharan Shyam K, Alter Blanche |
| Germline mutations in a DNA repair pathway are associated with familial colorectal cancer. JCI insight 2021 9 6 (18): . Xu Pingping, Sun Danfeng, Gao Yaqi, Jiang Yi, Zhong Ming, Zhao Gang, Chen Jinxian, Wang Zheng, Liu Qiang, Hong Jie, Chen Haoyan, Chen Ying-Xuan, Fang Jing-Yu |
| Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis. Breast cancer research and treatment 2020 Jun . Alter Blanche P, Best Ana |
| Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients. Cancers 2020 4 12 (4): . Del Valle Jesús, Rofes Paula, Moreno-Cabrera José Marcos, López-Dóriga Adriana, Belhadj Sami, Vargas-Parra Gardenia, Teulé Àlex, Cuesta Raquel, Muñoz Xavier, Campos Olga, Salinas Mónica, de Cid Rafael, Brunet Joan, González Sara, Capellá Gabriel, Pineda Marta, Feliubadaló Lídia, Lázaro Con |
| Two truncating variants in FANCC and breast cancer risk. Scientific reports 2019 Aug 9 (1): 12524. Dörk Thilo, Peterlongo Paolo, Mannermaa Arto, Bolla Manjeet K, Wang Qin, Dennis Joe, Ahearn Thomas, Andrulis Irene L, Anton-Culver Hoda, Arndt Volker, Aronson Kristan J, Augustinsson Annelie, Freeman Laura E Beane, Beckmann Matthias W, Beeghly-Fadiel Alicia, Behrens Sabine, Bermisheva Marina, Blomqvist Carl, Bogdanova Natalia V, Bojesen Stig E, Brauch Hiltrud, Brenner Hermann, Burwinkel Barbara, Canzian Federico, Chan Tsun L, Chang-Claude Jenny, Chanock Stephen J, Choi Ji-Yeob, Christiansen Hans, Clarke Christine L, Couch Fergus J, Czene Kamila, Daly Mary B, Dos-Santos-Silva Isabel, Dwek Miriam, Eccles Diana M, Ekici Arif B, Eriksson Mikael, Evans D Gareth, Fasching Peter A, Figueroa Jonine, Flyger Henrik, Fritschi Lin, Gabrielson Marike, Gago-Dominguez Manuela, Gao Chi, Gapstur Susan M, García-Closas Montserrat, García-Sáenz José A, Gaudet Mia M, Giles Graham G, Goldberg Mark S, Goldgar David E, Guénel Pascal, Haeberle Lothar, Haiman Christopher A, Håkansson Niclas, Hall Per, Hamann Ute, Hartman Mikael, Hauke Jan, Hein Alexander, Hillemanns Peter, Hogervorst Frans B L, Hooning Maartje J, Hopper John L, Howell Tony, Huo Dezheng, Ito Hidemi, Iwasaki Motoki, Jakubowska Anna, Janni Wolfgang, John Esther M, Jung Audrey, Kaaks Rudolf, Kang Daehee, Kapoor Pooja Middha, Khusnutdinova Elza, Kim Sung-Won, Kitahara Cari M, Koutros Stella, Kraft Peter, Kristensen Vessela N, Kwong Ava, Lambrechts Diether, Marchand Loic Le, Li Jingmei, Lindström Sara, Linet Martha, Lo Wing-Yee, Long Jirong, Lophatananon Artitaya, Lubi?ski Jan, Manoochehri Mehdi, Manoukian Siranoush, Margolin Sara, Martinez Elena, Matsuo Keitaro, Mavroudis Dimitris, Meindl Alfons, Menon Usha, Milne Roger L, Mohd Taib Nur Aishah, Muir Kenneth, Mulligan Anna Marie, Neuhausen Susan L, Nevanlinna Heli, Neven Patrick, Newman William G, Offit Kenneth, Olopade Olufunmilayo I, Olshan Andrew F, Olson Janet E, Olsson Håkan, Park Sue K, Park-Simon Tjoung-Won, Peto Julian, Plaseska-Karanfilska Dijana, Pohl-Rescigno Esther, Presneau Nadege, Rack Brigitte, Radice Paolo, Rashid Muhammad U, Rennert Gad, Rennert Hedy S, Romero Atocha, Ruebner Matthias, Saloustros Emmanouil, Schmidt Marjanka K, Schmutzler Rita K, Schneider Michael O, Schoemaker Minouk J, Scott Christopher, Shen Chen-Yang, Shu Xiao-Ou, Simard Jacques, Slager Susan, Smichkoska Snezhana, Southey Melissa C, Spinelli John J, Stone Jennifer, Surowy Harald, Swerdlow Anthony J, Tamimi Rulla M, Tapper William J, Teo Soo H, Terry Mary Beth, Toland Amanda E, Tollenaar Rob A E M, Torres Diana, Torres-Mejía Gabriela, Troester Melissa A, Truong Thérèse, Tsugane Shoichiro, Untch Michael, Vachon Celine M, Ouweland Ans M W van den, Veen Elke M van, Vijai Joseph, Wendt Camilla, Wolk Alicja, Yu Jyh-Cherng, Zheng Wei, Ziogas Argyrios, Ziv Elad, , , Dunning Alison M, Pharoah Paul D P, Schindler Detlev, Devilee Peter, Easton Douglas |
| Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility. Genetics in medicine : official journal of the American College of Medical Genetics 2017 8 20 (4): 452-457. Catucci Irene, Osorio Ana, Arver Brita, Neidhardt Guido, Bogliolo Massimo, Zanardi Federica, Riboni Mirko, Minardi Simone, Pujol Roser, Azzollini Jacopo, Peissel Bernard, Manoukian Siranoush, De Vecchi Giovanna, Casola Stefano, Hauke Jan, Richters Lisa, Rhiem Kerstin, Schmutzler Rita K, Wallander Karin, Törngren Therese, Borg Åke, Radice Paolo, Surrallés Jordi, Hahnen Eric, Ehrencrona Hans, Kvist Anders, Benitez Javier, Peterlongo Pao |
| Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients. Clinical genetics 2016 Jan . Lhota Filip, Zemankova Petra, Kleiblova Petra, Soukupova Jana, Vocka Michal, Stranecky Viktor, Janatova Marketa, Hartmannova Hana, Hodanova Katerina, Kmoch Stanislav, Kleibl Zden |
| Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proceedings of the National Academy of Sciences of the United States of America 2014 Oct 111 (42): 15172-7. Kiiski Johanna I, Pelttari Liisa M, Khan Sofia, Freysteinsdottir Edda S, Reynisdottir Inga, Hart Steven N, Shimelis Hermela, Vilske Sara, Kallioniemi Anne, Schleutker Johanna, Leminen Arto, Bützow Ralf, Blomqvist Carl, Barkardottir Rosa B, Couch Fergus J, Aittomäki Kristiina, Nevanlinna He |
| Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population. Molecular oncology 2013 Feb 7 (1): 85-100. Litim Nadhir, Labrie Yvan, Desjardins Sylvie, Ouellette Geneviève, Plourde Karine, Belleau Pascal, , Durocher Franci |
| Analysis of the novel fanconi anemia gene SLX4/FANCP in familial breast cancer cases. Human mutation 2013 Jan 34 (1): 70-3. Bakker Janine L, van Mil Saskia E, Crossan Gerry, Sabbaghian Nelly, De Leeneer Kim, Poppe Bruce, Adank Muriel, Gille Hans, Verheul Henk, Meijers-Heijboer Hanne, de Winter Johan P, Claes Kathleen, Tischkowitz Marc, Waisfisz Quint |
| Novel germline PALB2 truncating mutations in African American breast cancer patients. Cancer 2012 Mar 118 (5): 1362-70. Zheng Yonglan, Zhang Jing, Niu Qun, Huo Dezheng, Olopade Olufunmilayo |
| Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Human mutation 2011 Jun 32 (6): E2176-88. Hellebrand Heide, Sutter Christian, Honisch Ellen, Gross Eva, Wappenschmidt Barbara, Schem Christian, Deissler Helmut, Ditsch Nina, Gress Verena, Kiechle Marion, Bartram Claus R, Schmutzler Rita K, Niederacher Dieter, Arnold Norbert, Meindl Alfo |
| PALB2 analysis in BRCA2-like families. Breast cancer research and treatment 2011 Jun 127 (2): 357-62. Adank M A, van Mil S E, Gille J J P, Waisfisz Q, Meijers-Heijboer |
| Fanconi anemia gene mutations are not involved in sporadic Wilms tumor. Pediatric blood & cancer 2010 Oct 55 (4): 742-4. Adank Muriel A, Segers Heidi, van Mil Saskia E, van Helsdingen Yvette M, Ameziane Najim, van den Ouweland Ans M W, Wagner Anja, Meijers-Heijboer Hanne, Kool Marcel, de Kraker Jan, Waisfisz Quinten, van den Heuvel-Eibrink Marry |
| Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition. Carcinogenesis 2009 Nov 30 (11): 1898-902. García María J, Fernández Victoria, Osorio Ana, Barroso Alicia, Fernández Fernando, Urioste Miguel, Benítez Javi |
| The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features. Breast cancer research and treatment 2009 Jun . Barroso E, Pita G, Arias JI, Menendez P, Zamora P, Blanco M, Benitez J, Ribas G |
| Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families. Breast cancer research and treatment 2009 Feb 113 (3): 545-51. García María J, Fernández Victoria, Osorio Ana, Barroso Alicia, Llort Gemma, Lázaro Conxi, Blanco Ignacio, Caldés Trinidad, de la Hoya Miguel, Ramón Y Cajal Teresa, Alonso Carmen, Tejada María-Isabel, San Román Carlos, Robles-Díaz Luis, Urioste Miguel, Benítez Javi |
| Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families. Journal of human genetics 2008 53 (7): 579-91. Guénard Frédéric, Labrie Yvan, Ouellette Geneviève, Joly Beauparlant Charles, Simard Jacques, Durocher Francine, |
| PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nature genetics 2007 Feb 39 (2): 165-7. Rahman Nazneen, Seal Sheila, Thompson Deborah, Kelly Patrick, Renwick Anthony, Elliott Anna, Reid Sarah, Spanova Katarina, Barfoot Rita, Chagtai Tasnim, Jayatilake Hiran, McGuffog Lesley, Hanks Sandra, Evans D Gareth, Eccles Diana, , Easton Douglas F, Stratton Michael |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: